Immunocellular Therapeutics, Ltd.
8Patents
6Active
8Granted
39Portfolio score
Filing activity: Sep 29, 2004 → Feb 14, 2014 · 4 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8383768B2 | CD133 epitopes | Human Necessities | 29 | Active |
| US7435415B2 | Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) | Physics | 13 | Expired |
| US8604167B2 | CD133 epitopes | Human Necessities | 8 | Active |
| US10137182B2 | Cancer vaccines and vaccination methods | Chemistry; Metallurgy | 4 | Active |
| US7687607B2 | Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLS) | Physics | 3 | Active |
| US7435554B2 | Monoclonal antibodies and cell surface antigens for the detection and treatment of small cell lung cancer (SCLC) | Physics | 0 | Expired |
| US7498129B2 | Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof | Physics | 0 | Active |
| US7691376B2 | Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.